Funds with similar focus
|Addisco Value Partner Fund||Charlotte, North Carolina, United States|
|Arris Group||Georgia, Suwanee, United States|
|Aura Funds Management||Australia, Melbourne, Victoria|
|Conservation International Ventures||Arlington, United States, Virginia|
|Full Commit Partners||Japan, Tokyo|
|GeNi VC||Distrito Federal, Mexico, Mexico City|
|IFX Corporation||Florida, Hollywood, United States|
|Jiangsu Dingxin Capital Management||China, Jiangsu, Nanjing|
|L Catterton Asia||Central, Central Region, Singapore|
|Nader Group||Amman, Amman, Jordan|
|Original Capital||California, San Francisco, United States|
|RIC Capital Management||China, Shanghai|
|Strategic Year Holdings||China, Hong Kong, Hong Kong Island|
|Summa Digital||Stockholm, Stockholm County, Sweden|
|TOTAL Impact Capital||District of Columbia, United States, Washington|
|UVM 2 Venture Investments||Central, Central Region, Singapore|
|VIGO||China, Guangdong, Guangzhou|
|01 Jun 2022||-|
|$9M||28 Apr 2022||Mexico City, Mexico|
|$6M||16 Mar 2022||Austin, Texas, United States|
|$6M||11 Mar 2022||Austin, Texas, United States|
|$4M||22 Nov 2021||-|
|$2M||17 Nov 2021||Sao Paulo, São Paulo, Brazil|
Mercê do Bairro
|$9M||25 Oct 2021||-|
Mercê do Bairro
|$10M||21 Oct 2021||-|
|$5M||05 Aug 2021||San Francisco, California, United States|
– Encellin closed a $5.9M Seed financing round.
– The round was co-led by Khosla Ventures and SV Latam Capital, with participation from Sandhill Angels and Y Combinator.
– The new funding will be used to advance development of its technology platform and programs in hypoglycemia and hypocalcemia.
– Encellin will also expand into areas with readily available renewable cell sources and engineered cells, to encapsulate any cellular cargo in products from its proprietary platform.
– Encellin builds implantable “cell pouches” to treat chronic diseases.
– The company’s technology combines ad novel cell encapsulation technology with functional cell therapies to treat chronic diseases, starting with endocrine disorders.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.